Fundraising Fox

Euclises Pharmaceuticals

St. Louis, US · Founded 2011 · Delaware corporation · 4 known investors

Biotech

Founders & leadership

Euclises Pharmaceuticals was founded in 2011 by Robert W. Karr.

RW
Robert W. KarrFounder
BW
Bobby W. Sandage, Jr.Executive
JT
John TalleyNamed on SEC filing
RJ
Robert J. CalcaterraNamed on SEC filing

Board

CB
Charles BoltenBoard director
RR
Rick RyanBoard director
RDRajesh Devraj
Rajesh Devrajin𝕏Board directorVenture Partner at Atlas Venture
EM
Eduardo MartinezBoard director
RA
Robert A. BeardsleyBoard director

Investors · 4

iSelect FundSt. Louis · $250K – $2M
Atlas VenturereportedCambridge · $500K – $1Mvia Rajesh Devraj · board
Cultivation CapitalreportedSt. Louis · $100K – $3.5M
Missouri Technology CorporationreportedSt. Louis

Reported raises · per SEC filings

Form D private placements

$3.1M disclosed across 2 rounds · 2013–2015

▶$1.2MraisedDec 2016 · 5 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Charles A. BoltenDirector
  • John TalleyDirector
  • Robert J. CalcaterraDirector
  • Rajesh DevrajDirector
  • Rick RyanDirector
  • Robert A. BeardsleyDirector
  • Bobby W. Sandage, Jr.Executive Officer, Director
Offering amount
$2.7M
Amount sold
$1.2M
Minimum investment
$1
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$1.9MraisedOct 2015 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles BoltenDirector
  • Rick RyanDirector
  • Rajesh DevrajExecutive Officer, Director
  • John TalleyDirector
  • Robert W. KarrExecutive Officer, Director
  • Eduardo MartinezDirector
  • Robert A. BeardsleyDirector
  • Robert J. CalcaterraDirector
  • Bobby W. Sandage, Jr.Executive Officer, Director
Offering amount
$1.9M
Amount sold
$1.9M
First sale
Dec 2013
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Network of Entrepreneurs and Investors Driving Healthcare Innovationiselectfund.com · Oct 2016Euclises Pharmaceuticals Receives Notice Of Patent Allowance From European Patent Office For New Class Of Compounds For Treatment Of Cancer, Pain And Inflammation - BioSpacebiospace.com · Dec 2015Euclises Pharmaceuticals Co-Founder Named 2015 Power Medicine Maker - BioSpacebiospace.com · May 2015Euclises Pharmaceuticals Completes Nearly $2M Series A Funding - FinSMEsfinsmes.com · Apr 2015Euclises Announces Series A Financing | Fierce Biotechfiercebiotech.com · Sep 2014Euclises Pharmaceuticals Closes $1.3M Series A Financing - FinSMEsfinsmes.com · Sep 2014

Frequently asked questions

Who founded Euclises Pharmaceuticals?
Euclises Pharmaceuticals was founded by Robert W. Karr in 2011.
Who are Euclises Pharmaceuticals's investors?
Euclises Pharmaceuticals's investors include iSelect Fund, Atlas Venture, Cultivation Capital, Missouri Technology Corporation.
How much funding has Euclises Pharmaceuticals raised?
Euclises Pharmaceuticals has disclosed $3.1M raised across 2 rounds.
Where is Euclises Pharmaceuticals headquartered?
Euclises Pharmaceuticals is headquartered in St. Louis, US.